# Michael Lubitz

> Michael Lubitz is a seed investor at Ideaship backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Ideaship](https://shizune.co/investors/profile/ideaship)
- Total investments: 1
- Last investment: Jan 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/michael-lubitz-ph-d-340b7915

Michael Lubitz is a seed investor at Ideaship focused on Medical and Biotechnology. Michael Lubitz originally formed GTT Group as a global patent brokerage specializing in essential asset transactions with transnational competency. The patent brokerage soon evolved into an industry leader in patent valuation, patent acquisition, patent analysis, and strategic patent initiatives. Mr. Lubitz’s brokerage transactions have includedthe highest value per asset transaction and the single largest asset transfer between practicing entities. GTT’s Group’s success related to patent transactions has been in part attributed to its core competency in patent valuation. Mr. Lubitz has always emphasized patent valuation analysis before considering any transaction that may have significant consequence.Mr. Lubitz is regarded as a pioneer in patent valuation, having initiated GTT Group’s internal system of integrating actual transaction data within a complex modeling framework. The assessment methodology has been deployed across a wide variety of portfolios and businesses to confirm and identify pent up or undiscovered value. Mr. Lubitz is also the originator of the Patent Market Index or PMI, which is widely regarded as the benchmark economic index for patent activity within the United States.Prior to starting what would become GTT Group in 1997, Mr. Lubitz was in-house counsel to Kyocera Industrial Ceramics Corporation and then patent counsel to Shin-Etsu Handotai America. Mr. Lubitz is well known as a patent portfolio development specialist, having developed significant portfolios in the semiconductor and communications related areas that eventually led to substantial patent asset transactions. Mr. Lubitz also advised the American Association for the Advancement of Science on technology transfer and new venture creation issues in Japan. Before entering law school, Mr. Lubitz served as a systems specialist for Kyocera Corporation in Kyoto, Japan. Mr. Lubitz has a Bachelor of Science in General Business with an emphasis in Japanese from Arizona State University. He received his Juris Doctor from the University of San Diego, School of Law. At the University of San Diego he received the American Jurisprudence Award for his work in Ethics and Secured Transactions and served as an Associate Editor of the Journal for Contemporary Legal Issues.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Captis Biotechnology | Captis Biotechnology is a diagnostic company whose goal is to address major challenges in early disease detection. The technologies developed by Captis research and diagnostics are towards the treatment of chronic diseases such as cancer, cardiovascular and Alzheimer’s. |  | Seed | Jan 21, 2020 |  |

1 of 1 investments shown.

## About Ideaship

VC Fund · Portland, United States

Ideaship is patent development capital for early stage ventures.

5 contacts available at Ideaship.

| Name | Title | Profile |
| --- | --- | --- |
| Kazuki Kawakami | Co-Founder | https://shizune.co/investors/profile/kazuki-kawakami |
| Masa Murayama | Co-Founder | https://shizune.co/investors/profile/masa-murayama |
| Michael Lubitz | Co-Founder & General Partner | https://shizune.co/investors/profile/michael-lubitz |
| Amanda Oborne | Managing Director | https://shizune.co/investors/profile/amanda-oborne |
| Hiroo Morinaga | Co-Founder | https://shizune.co/investors/profile/hiroo-morinaga |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Michael Lubitz invest in?

Michael Lubitz invests primarily in Medical, Biotechnology and Health Diagnostics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Michael Lubitz last invest?

The most recent investment recorded for Michael Lubitz closed in Jan 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co